1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 234 results.

Thumbnail for Redefining the Horizon: A Deep Survival Mixture Meta-Analysis Quantifying the Statistical Cure Fraction of Cellular Therapies in Relapsed Multiple Myeloma

MM - 1520

Redefining the Horizon: A Deep Survival Mixture Meta-Analysis Quantifying the Statistical Cure Fraction of Cellular Therapies in Relapsed Multiple Myeloma

Haroon Alamy

Poster Presenter: Haroon Alamy

Thumbnail for Isolating the Anti-CD38 Component Effect in Newly Diagnosed Multiple Myeloma: A Component-Based Network Meta-Analysis of Phase 3 Randomized Trials

MM - 1523

Isolating the Anti-CD38 Component Effect in Newly Diagnosed Multiple Myeloma: A Component-Based Network Meta-Analysis of Phase 3 Randomized Trials

Raj Nandan Chennuri

Poster Presenter: Raj Nandan Chennuri

Thumbnail for Socioeconomic, Demographic, and Hospital-Level Predictors of In-Hospital Mortality in Multiple Myeloma: A 2022 National Inpatient Sample Analysis

MM - 1535

Socioeconomic, Demographic, and Hospital-Level Predictors of In-Hospital Mortality in Multiple Myeloma: A 2022 National Inpatient Sample Analysis

Kriti Yadav

Poster Presenter: Kriti Yadav

Thumbnail for Impact of Daratumumab-Based Regimens on Survival and Minimal Residual Disease Negativity in Multiple Myeloma: A Systematic Review and Meta-Analysis

MM - 1537

Impact of Daratumumab-Based Regimens on Survival and Minimal Residual Disease Negativity in Multiple Myeloma: A Systematic Review and Meta-Analysis

Anubhuti Sharma

Poster Presenter: Anubhuti Sharma

$Thumbnail for Cardiovascular Adverse Event Reporting Patterns With BCMA-Directed CAR-T and BCMA/GPRC5D Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A FAERS Disproportionality Analysis$

MM - 1542

Cardiovascular Adverse Event Reporting Patterns With BCMA-Directed CAR-T and BCMA/GPRC5D Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A FAERS Disproportionality Analysis

B?sranur Yilmaz

Poster Presenter: B?sranur Yilmaz

$Thumbnail for Efficacy and Safety Outcomes of Teclistamab in Relapsed/Refractory Multiple Myeloma: A Systematic Review$

MM - 1547

Efficacy and Safety Outcomes of Teclistamab in Relapsed/Refractory Multiple Myeloma: A Systematic Review

Maha Hameed

Poster Presenter: Maha Hameed

MM - 1573

30-Day Non-Relapse Mortality In Multiple Myeloma Patients Treated with Bispecific T-cell Engagers: A Fear Analysis

Elias Tayar

Poster Presenter: Elias Tayar

$Thumbnail for True Extramedullary Versus Paraskeletal/Paramedullary Disease as Determinants of CAR-T Outcomes in Relapsed or Refractory Multiple Myeloma$

MM - 1579

True Extramedullary Versus Paraskeletal/Paramedullary Disease as Determinants of CAR-T Outcomes in Relapsed or Refractory Multiple Myeloma

Sri Pranita Cherukuri

Poster Presenter: Sri Pranita Cherukuri

Thumbnail for The Calculus of Relapse: A Neural Ordinary Differential Equation Model of Continuous Disease Acceleration Following CAR-T vs Bispecific Therapy in Multiple Myeloma

MM - 1585

The Calculus of Relapse: A Neural Ordinary Differential Equation Model of Continuous Disease Acceleration Following CAR-T vs Bispecific Therapy in Multiple Myeloma

Iman Khan

Poster Presenter: Iman Khan